ELTX NASDAQ
Elicio Therapeutics, Inc.
1W: +4.3%
1M: -24.7%
3M: -41.8%
YTD: -76.2%
1Y: -82.5%
$1.92
+0.00 (+0.00%)
Weekly Expected Move ±8.3%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-38M
Net Income
+30.7% YoY
$-38M
Free Cash Flow
-7.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-774.6%
ROA-124.4%
ROIC2147.3%
Valuation
P/E-0.9
P/B4.7
EV/EBITDA-1.6
Leverage
Debt/Equity1.78
Current Ratio2.77
Interest Cov.-26.2x
Quality Scores
Piotroski F4/9
Altman Z-13.14
Beneish M0.00